Xingchen Zhou

888 citations
15 papers · 646 indexed · h-index 9
Topics
MicroRNA in disease regulation (5 papers)Topic Modeling (3 papers)Cancer-related molecular mechanisms research (3 papers)

In The Last Decade

Xingchen Zhou

14 papers receiving 639 citations

Peers

Xingchen Zhou
Comparison fields: 5 of 90
  • Molecular Biology 203
  • Computer Vision and Pattern Recognition 162
  • Cancer Research 160
  • Artificial Intelligence 131
  • Biomedical Engineering 98
Replace Xiuhui Chen with:
Xiuhui Chen China
Zhenqiu Liu United States
Pierre Gestraud France
Jianchao Wang China
Vilppu J. Tuominen Finland
P. Ravazoula Greece
John Lai Australia
Elisa Ficarra Italy
Safoora Yousefi United States
Stephanie Robertson Sweden
Xingchen Zhou relative to Xiuhui Chen China Xiuhui Chen's profile →
Citations per field
00.5×10×20×31×
Xiuhui Chen · 1×
Citations per year

Countries citing papers authored by Xingchen Zhou

Since Specialization
Citations

This map shows the geographic impact of Xingchen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingchen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingchen Zhou more than expected).

Fields of papers citing papers by Xingchen Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingchen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingchen Zhou. The network helps show where Xingchen Zhou may publish in the future.

Co-authorship network of co-authors of Xingchen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xingchen Zhou. A scholar is included among the top collaborators of Xingchen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingchen Zhou. Xingchen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 1
3 6
4 10
5 4
6 8
7 105
8 7
9 105
10 18
11 63
12 31
13
MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway.
38
14 85
15 165

About Xingchen Zhou

Xingchen Zhou is a scholar working on Cancer Research, Rehabilitation and Obstetrics and Gynecology, having authored 15 papers that have together received 646 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Topic Modeling (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (160 citations), Computer Vision and Pattern Recognition (162 citations) and Genetics (67 citations). Xingchen Zhou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Dacheng Tao, Chun Chen, Xiao Liu, Jiajun Bu, Mingli Song, Ning Zheng, Yiming Wu, Ming Xu, Wen Di and Lan Dai. Their work appears in journals such as PLoS ONE, Toxicology and Applied Pharmacology and Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026